Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Name: Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
Published: 2014
License: Public Domain

Vyne Therapeutics Inc. · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

rash due to epidermal growth factor receptor inhibitors, egfri, epidermal growth factor receptor inhibition, skin toxicity, topical, doxycycline, foam, phase ii, cetuximab, panitumumab, vectibix, erbitux

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 866324
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.